Literature DB >> 16186060

Skeletal muscle fibres synthesis in heart failure: role of PGC-1alpha, calcineurin and GH.

Giorgio Vescovo1, Barbara Ravara, Valerio Gobbo, Annalisa Angelini, Luciano Dalla Libera.   

Abstract

BACKGROUND: Patients with congestive heart failure (CHF) have decreased exercise capacity because of muscle fatigability. Symptoms are due to a specific myopathy with increased expression of fast type II fibres, fast MHCs and muscle atrophy. PGC-1alpha, a potent transcriptional coactivator for nuclear receptors, induces mitochondrial myogenesis and the preferential synthesis of slow fibres. IGF1-Calcineurin stimulation can lead to increased expression of PGC-1alpha.
METHODS: We investigated the levels of PGC-1alpha during progression and regression of skeletal myopathy in the soleus muscle of rats with right heart failure secondary to monocrotaline-induced pulmonary hypertension. We used GH to stimulate the IGF1-calcineurin-PGC-1alpha axis.
RESULTS: The slow MHC1 decreased from 90.6+/-0.5 to 71.7+/-2.2 in the CHF rats (p<0.00001) and increased to 82.1+/-1.8 after GH (p<0.00002). Western blot analysis showed that PGC-1alpha is significantly decreased in CHF, while it came back to control values after GH. Cytochrome c was decreased in CHF and returned to control values with GH. Troponin I was expressed solely as slow isoform in the control soleus, while the fast isoform appeared in CHF. Its expression returned to control values after GH.
CONCLUSIONS: We conclude that PGC-1alpha plays an important role in regulating slow fibres expression. PGC1-1alpha is in turn regulated by the IGF1-calcineurin axis. GH by increasing the circulating levels of IGF1, enhanced the expression of slow MHC1, TnI and the synthesis of mitochondria.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16186060     DOI: 10.1016/j.ijcard.2004.10.059

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  17 in total

Review 1.  The emerging role of skeletal muscle oxidative metabolism as a biological target and cellular regulator of cancer-induced muscle wasting.

Authors:  James A Carson; Justin P Hardee; Brandon N VanderVeen
Journal:  Semin Cell Dev Biol       Date:  2015-12-01       Impact factor: 7.727

2.  Mitochondrial Function Is Compromised in Cortical Bone Osteocytes of Long-Lived Growth Hormone Receptor Null Mice.

Authors:  Zhongbo Liu; Maria E Solesio; Mitchell B Schaffler; Dorra Frikha-Benayed; Clifford J Rosen; Haim Werner; John J Kopchick; Evgeny V Pavlov; Andrey Y Abramov; Shoshana Yakar
Journal:  J Bone Miner Res       Date:  2018-09-14       Impact factor: 6.741

3.  The effects of tesamorelin on phosphocreatine recovery in obese subjects with reduced GH.

Authors:  Hideo Makimura; Caitlin A Murphy; Meghan N Feldpausch; Steven K Grinspoon
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

4.  Redox Biology of Peroxisome Proliferator-Activated Receptor-γ in Pulmonary Hypertension.

Authors:  Victor Tseng; Roy L Sutliff; C Michael Hart
Journal:  Antioxid Redox Signal       Date:  2019-02-25       Impact factor: 8.401

5.  The association of growth hormone parameters with skeletal muscle phosphocreatine recovery in adult men.

Authors:  Hideo Makimura; Takara L Stanley; Noelle Sun; Mirko I Hrovat; David M Systrom; Steven K Grinspoon
Journal:  J Clin Endocrinol Metab       Date:  2010-12-22       Impact factor: 5.958

6.  Relationship between serum IGF-1 and skeletal muscle IGF-1 mRNA expression to phosphocreatine recovery after exercise in obese men with reduced GH.

Authors:  Sulaiman R Hamarneh; Caitlin A Murphy; Cynthia W Shih; Walter Frontera; Martin Torriani; Javier E Irazoqui; Hideo Makimura
Journal:  J Clin Endocrinol Metab       Date:  2014-11-06       Impact factor: 5.958

7.  Muscle oxidative capacity during IL-6-dependent cancer cachexia.

Authors:  James P White; Kristen A Baltgalvis; Melissa J Puppa; Shuichi Sato; John W Baynes; James A Carson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-12-09       Impact factor: 3.619

8.  Skeletal muscle mitochondrial dysfunction precedes right ventricular impairment in experimental pulmonary hypertension.

Authors:  Irina Enache; Anne-Laure Charles; Jamal Bouitbir; Fabrice Favret; Joffrey Zoll; Daniel Metzger; Monique Oswald-Mammosser; Bernard Geny; Anne Charloux
Journal:  Mol Cell Biochem       Date:  2012-10-26       Impact factor: 3.396

9.  PGC1α-mediated mitofusin-2 deficiency in female rats and humans with pulmonary arterial hypertension.

Authors:  John J Ryan; Glenn Marsboom; Yong-Hu Fang; Peter T Toth; Erik Morrow; Nancy Luo; Lin Piao; Zhigang Hong; Kyle Ericson; Hannah J Zhang; Mei Han; Chad R Haney; Chin-Tu Chen; Willard W Sharp; Stephen L Archer
Journal:  Am J Respir Crit Care Med       Date:  2013-04-15       Impact factor: 21.405

10.  IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the ApcMin/+ mouse.

Authors:  James P White; Melissa J Puppa; Shuichi Sato; Song Gao; Robert L Price; John W Baynes; Matthew C Kostek; Lydia E Matesic; James A Carson
Journal:  Skelet Muscle       Date:  2012-07-06       Impact factor: 4.912

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.